Matches 1 - 50 out of 337 1 2 3 4 5 6 7 >
Match Document Document Title
7622576 Halide-free glucosamine base and method of preparation  
A glucosamine base having a pure level of at least about 99.0 wt. % and a maximum halide content of 0.01 wt. %. The pure glucosamine base is prepared by reacting a glucosamine halide, e.g.,...
7612049 Method of inhibition the growth of algae  
The inhibition of Chlorophyta growth in water needed to be treated can be accomplished by the addition of about 100 ppm glucosamine. The inhibition of Microcystic aeruginosa and Microcystis...
7605146 Process for producing an amide compound  
There is disclosed a process for producing an amide compound, which process is characterized in that a compound having an amino group are reacted with a polyaminopolycarboxylic acid anhydride in...
7592327 Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils  
A pharmaceutical composition for the treatment and/or prophylaxis of diseases caused by type I hypersensitivity reactions consisting essentially of Glicophosphopeptical, or pure Nigella Sativa ...
7553820 Mevalonic acid derivatives  
This invention provides compounds having excellent antitumor activity, which are represented by the following formulae in which R 1 , R 2 , R 3 , m, n and R 4 have the significations as...
7544671 Stabilized hyaluronan preparations and related methods  
Stabilized hyaluronan preparations wherein hyaluronan is combined with a polyglycol, such as polyethylene glycol. Stabilized hyaluronan preparations of this invention may maintain their viscosity...
7504387 Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis  
The invention provides compositions and methods useful for the treatment and/or prevention of interstitial cystitis and/or a related urinary tract condition in man or in animals. Specifically,...
7498317 Antibacterial agents and process for producing the same  
An antibacterial agent showing a high affinity for Helicobactor pyroli and having an antibacterial effect specific to H. Pyroli. The agent has a chemical structure wherein an antibacterial...
7494674 Nutraceutical with tart cherries and method of treatment therewith  
The present disclosure provides a nutraceutical for the use of a vacuolar flavonoid pigment from a natural source such as tart cherries as an additional compound as part of a mixture including at...
7485718 Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines  
A process for the synthesis of beta linked low molecular weight polymers of galactosamine and glucosamine has been developed. Through the use of high amounts of activating agents, efficient...
7485629 Composition and method for treatment of joint damage  
The invention provides compositions useful for the treatment and/or prevention of damage to diarthrodial (synovial) joints and, in particular, traumatic synovitis, inflammation of the synovial...
7482026 Compositions and methods directed towards sore muscles and joints  
Chemical formulations and methods for reducing muscle and joint soreness are disclosed. A representative chemical formulation includes compounds such as a selenium-compound, chondroitin sulfate,...
7468195 Skin treatment preparation  
A skin treatment preparation including carriers, a medicinal vector encapsulating a plant extract (Cucumis melo protein extract) rich in reductase, catalase and superoxide dismutase is...
7435812 Method for preparing a glucosamine compound and compound thus obtained  
Method for preparing a compound comprising protonated glucosamine and Cl − , Na + and SO 4 2− ions, in which (a) glucosamine hydrochloride and a stoichiometric excess of sodium sulphate are...
7429573 Method for increasing the bone mineral density and bone micro-architecture or connectivity of a mammal using N-acylated glucosamines  
A method of treating a mammal for a purpose selected from the group consisting of (a) increasing bone mineral density (BMD), (b) treating low BMD, (c) preventing and treatment of low impact...
7425573 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration  
Treating or preventing degeneration or destruction of articular cartilage and/or subchondral bone in the affected joint of a mammal is accomplished by administering a compound of formula (I),...
7416748 Arthritis phyto-nutraceutical synergistic composition  
A Phytoceutical composition for the prevention and treatment of arthritis is provided. A specific combination of extracts of plants and nutraceuticals is taught, as well as principles for varying...
7393937 N-acetylglucosamine derivatives and use thereof  
The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external...
7388001 Halide-free glucosamine sulfate compositions and methods of preparation  
Glucosamine sulfate having a purity of at least about 99 wt. %, and a maximum halide content of about 0.01 wt. %. Preferably, the glucosamine sulfate is stabilized by coating it with at least one...
7388000 Halide-free glucosamine phosphate compositions and methods of preparation  
Glucosamine phosphate having a purity of at least about 99 wt. %, and a maximum halide content of about 0.01 wt. %. Preferably, the glucosamine phosphate is stabilized by coating it with at least...
H002218 Glucosamine and method of making glucosamine from microbial biomass  
Glucosamine suitable for human or animal consumption is disclosed. The glucosamine is derived from microbial biomass containing chitin. Suitable starting materials include substantially uniform...
7345031 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use  
Hydrophilic transportable N-linked glycosyl dopaminergic prodrug compounds according to FORMULA V and methods of their use, wherein, Ring 1 comprises an aryl or heteroaryl ring having 4...
7345030 Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals  
The present invention is directed to the use of N-acetyl-D-glucosamine to treat organ lesions caused by toxicants and drugs. The present invention is also directed to a method for treating organ...
7338943 Hyaluronic acid in soft gel form  
An orally administered soft gelatin formulation preparation of low molecular weight Hyaluronic Acid (HA) for use as a nutritional supplement to provide the primary benefit of internally causing the...
7338942 Composition and method for maintaining healthy mobile joints and cartilage  
Compositions and methods for maintaining healthy mobile joints and cartilage in humans and animals are disclosed. The composition comprises glucosamine and chondroitin dispersed in a...
7335384 Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith  
The present disclosure describes a novel composition for the treatment and/or prevention of neurogenic inflammation. Such composition is also useful in the treatment and/or prevention of disease...
7323452 Method for the accelerated in vivo removal of ethanol  
A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as...
7316989 Compositions inducing plants disease-resistance and process for producing the same  
There is provided a plant disease resistance-inducing composition comprising a filamentous fungus-derived glycosphingolipid. There is also provided a method for controlling a plant disease,...
7259152 Methods and compositions using sulodexide for the treatment of diabetic nephropathy  
The present invention provides oral formulations of Sulodexide for the treatment of diabetic nephropathy in patients with both insulin dependent and non-insulin dependent diabetes mellitus. Oral...
7252828 Polysaccharide vaccine for staphylococcal infections  
The invention relates to compositions of the capsular polysaccharide/adhesin (PS/A) of staphylococci . The PS/A may be isolated or synthesized and includes various modifications to the structure...
7214667 Drugs against articular failure  
The object of the present invention is to provide a composition which exerts a higher effect on recovering health from articular disorders than that attained by amino sugars and glycosaminoglycans....
7214666 Composition of orally administered nutritional supplements to repair articular cartilage  
Provided is a synergistic combination of nutritional supplements classified as Nutraceuticals and further combined with antioxidant vitamins and minerals that, when orally administered to mammals,...
7202230 Use of hyaluronic acid derivatives in the preparation of biomaterials with a physical haemostatic and plugging activity  
The present invention describes the use of polysaccharide derivatives for the preparation of biocompatible and biodegradable biomaterials with absorbent properties for body fluids and physical...
7195675 Chitosan-containing polysaccharide, method for preparing the same and use thereof  
The present invention herein provides a chitosan-containing polysaccharide and a method for the preparation thereof as well as a medicine and a food containing the polysaccharide. The...
7157431 Compositions of plant carbohydrates as dietary supplements  
Compositions of plant carbohydrates for dietary supplements and nutritional support for promotion and maintenance of good health. Defined nutritionally effective amounts of one to eleven essential...
7153877 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome  
A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and...
7151099 Use of taurolidine and/or taurultam for treatment of abdominal cancer and/or for the prevention of metastases  
Taurolidine and/or taurultam is administered during and after surgical removal of a cancerous tumor to treat abdominal cancer.
7141556 Process for the preparation of glucosamine salts  
This invention relates to a process for the preparation of glucosamine sulfate, glucosamine hydroiodide, glucosamine pyruvate, glucosamine phosphate or their mixtures with glucosamine...
7138386 Preventives or remedies for arthritis  
The present invention relates to pharmaceuticals, foods and drinks, food additives, animal feeds and feed additives comprising an N-acylated hydroxyproline derivative or a salt thereof, and an...
7138149 Dietary supplements and methods for treating pain and inflammation  
The invention provides compositions such as dietary supplements. Such compositions can be used to reduce pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions...
7119110 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome  
A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and...
7119079 Bioadhesive pharmaceutical compositions  
Disclosed are compounds having the formula wherein R 2 is hydrogen, a monomeric glycoside or an oligomeric glycoside, R 3 is hydrogen, a monomeric glycoside, an oligomeric glycoside, or a...
7115588 Methods for treating a breach or puncture in a blood vessel  
The present invention relates to compositions comprising semi-crystalline β-1-4-N-acetylglucosamine polymers (p-GlcNac) and methods utilizing such polymers modulation of vascular structure and/or...
7101859 Use of lipid conjugates in the treatment of diseases  
The invention provides novel methods for treating disease based upon the medicinal use of lipids and phospholipids covalently bound to physiologically acceptable monomers or polymers....
7098195 Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells  
The present invention provides compositions and methods for inhibiting cell migration, e.g., lymphocytes and inflammation. The invention also provides an improved process for preparing fluorinated...
RE39245 Galactopyranosides and their use  
The present invention relates to simplified synthesis, new carbohydrate-based products and practical use of different carbohydrate-based products. Examples of these are (Galα1-3Gal),...
7074775 Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders  
A compound is provided that has the formula NH 2 CH 2 CH 2 CH 2 C(O)N—R (I) ...
7074774 Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for treating cardio-cerebrovascular anoxemia  
The present invention has disclosed a use of N-acetyl-D-glucosamine in the manufacture of a medicament for resisting cardiac and cerebral ischemia and oxygen-deficiency. N-acetyl-D-glucosamine can...
7049300 C-glycoside compounds for stimulating the synthesis of glycosaminoglycans  
C-glycoside compounds are suited for stimulating the synthesis of glycosaminoglycans containing a D-glucosamine and/or N-acetyl-D-glucosamine residue, advantageously hyaluronic acid, and/or...
7041657 Compositions and methods for modulation of vascular structure and/or function  
The present invention relates to compositions comprising semi-crystalline β-1-4-N-acetylglucosamine polymers (p-GlcNac) and methods utilizing such polymers modulation of vascular structure and/or...
Matches 1 - 50 out of 337 1 2 3 4 5 6 7 >